Skip to content

Scoring System for Thyroid Gland Pathologies

A New Scoring System in the Diagnosis of Thyroid Gland Pathologies

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04904159
Enrollment
300
Registered
2021-05-27
Start date
2021-05-01
Completion date
2023-05-01
Last updated
2021-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer, Thyroid Nodule

Keywords

TI-RADS, Bethesda

Brief summary

Although anamnesis and physical examination remain the place in the evaluation of patients today; laboratory values, imaging methods and pathology results have come to the fore in the decision-making of surgery for patients. As a result of all other criteria, a follow-up decision can be changed in a patient with a single fine needle aspiration biopsy result, or despite all the examinations the investigators have, a clear result cannot be achieved, and patient management may be disrupted. A holistic approach to thyroid gland pathologies is planned thanks to the scoring system that will be created in this study.

Detailed description

In routine clinical practice, the criteria the investigators consider during the pre - op period in patients evaluated due to thyroid pathologies include anamnesis, physical examination, laboratory values, especially thyroid function, thyroid-neck ultrasonographies, fine needle aspiration biopsies, according to which decisions about operation or nonoperative follow-up are made with the patient. The investigators aim to create a common scoring system by taking into account the pathology results of patients who have undergone thyroidectomy and comparing these results with the results of pre-op examination and thus to address patient management in a more objective and comprehensive way.

Interventions

PROCEDUREThyroidectomy

total thyroidectomy

PROCEDURELobectomy

Lobectomy

Sponsors

Dr. Lutfi Kirdar Kartal Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients who undergone surgery for thyroid gland pathologies

Exclusion criteria

* patients who did not want to be involved in the study * patients who missed in the follow-up period * pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
AgeBefore SurgeryYears
GenderBefore SurgeryMale - Female
Smoking StatusBefore SurgeryYes or No
Radiation to the Neck AreaBefore SurgeryYes or No
History of ThyroiditisBefore SurgeryYes or No
Family HistoryBefore SurgeryPresence of family members with any thyroid pathologies especially thyroid cancer
ComplaintBefore SurgeryMonths
Thyroid Imaging Reporting and Data System ( TIRADS ) scoreBefore surgeryRadiological features of throid nodule ( minimum value is 1 maximum value is 5 ); thyroid nodule which has a higher value means a worse outcome
Bethesda classification system for thyroid fine needle aspiratesBefore surgeryHistopathological features of thyroid nodule ( minimum value is 1 maximum value is 6 ) thyroid nodule which has higher value means a worse outcome
Thyroid Stimulating Hormone ( TSH ) levelsBefore surgeryit is a hormone secreted from the pituitary gland and triggers the functioning of the thyroid gland ( cut of values are 0.5 - 5.0 mIU / L )
Pathology resultsImmediately after the surgeryThe result of the throid gland part sent to the pathology unit after surgery ( the results can be benign or malign )

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026